The American Cancer Society has updated its cervical cancer screening guidelines, which include guidance for self-collection and when to stop screening. The guidelines were published Dec. 4 in CA: A Cancer Journal for Clinicians.
The FDA approved the first at-home screening test for cervical cancer on May 9. A study published June 6 in JAMA Internal Medicine found that mailed self-collection kits improved cervical cancer screening rates among racial or ethnic minority populations.
Here are three things to know about the new guidelines:
- Although in-office, physician-collected cervical specimens remain the preferred method for primary HPV testing, the guidelines now allow for self-collection as an acceptable screening method.
- For patients at an average risk of cervical cancer with consecutive negative results, HPV testing is safe to cease at age 65.
- Screening intervals and repeat testing are recommended depending on individual risk factors and previous test results.
Read the full screening guidelines here.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
